Sexual dysfunctions induced by antipsychotic medications in patients with schizophrenia

被引:0
|
作者
Tumuklu, Mevhibe N. [1 ]
Ulas, Halis [1 ]
Akdede, Berna Binnur Kivircik [1 ]
Alptekin, Koksal [1 ]
机构
[1] Dokuz Eylul Univ, Tip Fak, Psikiyatri AD, Izmir, Turkey
来源
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词
Schizophrenia; sexual dysfunction; antipsychotic medications; HALOPERIDOL; CLOZAPINE; SCALE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Sexual dysfunctions are common among patients with schizophrenia. These disorders may also impair the compliance with antipsychotic medications and have a negative impact on quality of life. The objective of this study was to determine the prevalence of sexual dysfunctions and related factors in clinically stable patients who were on antipsychotic treatment. Method: The study population included 76 patients with schizophrenia. Sexual dysfunctions were investigated by UKU (UKU, Udvalg for Kliniske Undersegelser) side effect rating scale. Results: UKU showed that 36.8% of all the patients had decreased sexual desire, and among the male patients 36.2% of them had erectile dysfunction and 23.4% had problems with ejaculation. Among the female patients 20.7% had amenorrhea. The ratio of decreased sexual desire detected by UKU was higher in male patients compared to the ratio in female patients. The patients with decreased sexual desire had higher PANSS negative sub-scores than the ones without decreased sexual desire. Conclusions: These results show that sexual dysfunctions are highly common among patients with schizophrenia. Moreover, these results support the efficiency of UKU side effect rating scale in detecting sexual dysfunctions induced by antipsychotic medications in patients with schizophrenia.
引用
收藏
页码:S27 / S31
页数:5
相关论文
共 50 条
  • [31] Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone
    Mullen, B
    Brar, JS
    Vagnucci, AH
    Ganguli, R
    SCHIZOPHRENIA RESEARCH, 2001, 48 (01) : 155 - 156
  • [32] Sexual dysfunctions, internalized stigma and quality of life in patients with schizophrenia
    Bejar, A.
    Smaoui, N.
    Gassara, I.
    Feki, R.
    Omri, S.
    Bouali, M. Maalej
    Charfi, N.
    Ben Thabet, J.
    Zouari, L.
    Maalej, M.
    EUROPEAN PSYCHIATRY, 2023, 66 : S132 - S132
  • [33] The relationships between sexual dysfunctions, psychopathology and treatment in patients with schizophrenia
    Bejar, A.
    Smaoui, N.
    Feki, R.
    Gassara, I.
    Omri, S.
    Charfi, N.
    Ben Thabet, J.
    Zouari, L.
    Bouali, M. Maalej
    Maalej, M.
    EUROPEAN PSYCHIATRY, 2023, 66 : S132 - S132
  • [34] The relationships between sexual dysfunctions, psychopathology and treatment in patients with schizophrenia
    Bejar, A.
    Smaoui, N.
    Gassara, I.
    Feki, R.
    Omri, S.
    Bouali, M. Maalej
    Charfi, N.
    Ben Thabet, J.
    Zouari, L.
    Maalej, M.
    EUROPEAN PSYCHIATRY, 2023, 66 : S132 - S132
  • [35] Antipsychotic medications and the progression of upper respiratory infection to pneumonia in patients with schizophrenia
    Chang, Chi-Kang
    Chen, Pao-Huan
    Pan, Chun-Hung
    Su, Sheng-Shiang
    Tsai, Shang-Ying
    Chen, Chiao-Chicy
    Kuo, Chian-Jue
    SCHIZOPHRENIA RESEARCH, 2020, 222 : 327 - 334
  • [36] Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
    Keefe, Richard
    Bilder, Robert M.
    Davis, Sonia M.
    Harvey, Philip D.
    Palmer, Barton W.
    Gold, James M.
    Meltzer, Herbert Y.
    Green, Michael F.
    Capuano, George
    Stroup, T. S.
    McEvoy, Joseph P.
    Swartz, Marvin S.
    Rosenheck, Robert A.
    Perkins, Diana O.
    Davis, Clarence E.
    Hsiao, John K.
    Lieberman, Jeffrey A.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S244 - S245
  • [37] Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
    Keefe, Richard S. E.
    Bilder, Robert M.
    Davis, Sonia M.
    Harvey, Philip D.
    Palmer, Barton W.
    Gold, James M.
    Meltzer, Herbert Y.
    Green, Michael F.
    Capuano, George
    Stroup, T. Scott
    McEvoy, Joseph P.
    Swartz, Marvin S.
    Roscnheck, Robert A.
    Perkins, Diana O.
    Davis, Clarence E.
    Hsiao, John K.
    Lieberman, Jcffrey A.
    ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (06) : 633 - 647
  • [38] Schizophrenia and adjunctive aripiprazole for antipsychotic-induced sexual dysfunction
    Sulejmanpasic-Arslanagic, G.
    Bise, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S896 - S897
  • [39] Costs of non-compliance with antipsychotic medications among patients with schizophrenia
    Salas, M.
    Zuluaga, A.
    Hughes, D.
    Lebmeier, M.
    Vardeva, K.
    Pisu, M.
    Shinogle, J.
    VALUE IN HEALTH, 2008, 11 (03) : A125 - A125
  • [40] The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia
    Chen, Lei
    McCombs, Jeffrey S.
    Park, Jinhee
    VALUE IN HEALTH, 2008, 11 (01) : 34 - 43